CenterWatch Announces — Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup Sponsored by Oracle Health Sciences Webinar Jan. 26, 2021

[ad_1]

WCG CenterWatch

WCG CenterWatch

Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

A Free CenterWatch Webinar, Sponsored by Oracle Health Sciences

Tuesday, Jan. 26, 2020, 1:00 p.m.-2:00 p.m. EST

http://cwinfo.centerwatch.com/cw-web21126-reducing-complexity-in-starting-clinical-trials-more-patients-faster-startup

Staying ahead of technological advancements is integral to success in today’s digital era. But keeping up and following the right course has its challenges when daily operations impinge upon efforts to think ahead.

Want to improve clinical trial efficiency and outcomes?

This free webinar shows attendees how to streamline trials, ultimately getting new therapies to market faster.

Sites, sponsors and contract research organizations (CROs) can adapt to this new normal — with its increasing complexity, longer initiation times and chronic under-enrollment — with technological solutions that enhance communication and collaboration with sites.

Oracle Health Sciences’ predictive analytics combined with Cognizant Healthcare and Life Sciences’ site-centric Shared Investigator Platform (SIP) means solutions for virtual monitoring, study oversight, and electronic document exchange and collaboration. This eliminates redundancy for sites and delivers better outcomes for sponsors and CROs.

The presenters will share how the Oracle/Cognizant tools allow one to move ahead. David Morin, MD, FACP, CPI, FACRP, Director of Research for Holston Medical Group; Jimmy Bechtel, the Society for Clinical Research Sites’ Director of Innovation and Engagement; Patricia Lorusso, DO, a Professor of Medicine at the Yale School of Medicine and the Associate Director of Experimental Therapeutics at Yale Cancer Center; Larissa Comis, the Product Lead for Cognizant Healthcare and Life Sciences’ Shared Investigator Platform; and Sujay Jadhav, Global Vice President of Product at Oracle Health Sciences will explain how to:

  • Reduce study startup cycle times by harmonizing processes and common documents across studies
  • Automate workflows for the management of contacting and collecting of site documentation for IRB/EC submissions
  • Increase data reliability, transparency and regulatory compliance
  • Simplify and optimize clinical trials, driving productivity gains
  • Enable transparent and enhanced communications and collaborations with sponsor/CRO study teams
  • Reduce the study burden on sites by using a centralized site profile that is maintained by the site and leveraged across multiple studies by sponsors/CROs

This free webinar is the key to elevating clinical trial processes and streamlining collaboration.

Webinar Details:

Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

A Free CenterWatch Webinar, Sponsored by Oracle Health Sciences

Tuesday, Jan. 26, 2020, 1:00 p.m.-2:00 p.m. EST

http://cwinfo.centerwatch.com/cw-web21126-reducing-complexity-in-starting-clinical-trials-more-patients-faster-startup

Tuition:

$287 per site

Easy Ways to Register:

Online: http://cwinfo.centerwatch.com/cw-web21126-reducing-complexity-in-starting-clinical-trials-more-patients-faster-startup

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

[ad_2]

Leave a Reply